John F. Paolini is VP at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have made 5 open-market trades across 1 company since 2020, most recently 2026-09-01.
CIK 0001741533
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KNSA | 69,922 | $5.5M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KNSA | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $53.71 | $3.1M | +0.1% | -12.5% | +30.4% |
| KNSA | SELL | 2026-03-02 | 2026-03-04 | $44.82 | $1.8M | -0.4% | +6.1% | +0.5% |
| KNSA | SELL · 10b5-1 | 2025-10-31 | 2025-11-04 | $37.14 | $6.1M | +2.1% | +3.8% | +13.1% |
| KNSA | SELL · 10b5-1 | 2025-08-06 | 2025-08-08 | $32.55 | $1.9M | +2.8% | +13.2% | +19.6% |
| KNSA | SELL · 10b5-1 | 2025-05-07 | 2025-05-09 | $27.00 | $5K | +0.5% | +16.7% | +27.3% |
| KNSA | SELL · 10b5-1 | 2024-09-03 | 2024-09-04 | $26.10 | $3.1M | -2.3% | -4.9% | -17.8% |
| KNSA | SELL · 10b5-1 | 2024-07-23 | 2024-07-25 | $26.31 | $1.2M | -6.5% | +6.1% | +3.4% |
| KNSA | SELL · 10b5-1 | 2024-03-01 | 2024-03-05 | $21.77 | $820K | -1.6% | -11.1% | -3.0% |
| KNSA | SELL · 10b5-1 | 2024-02-27 | 2024-02-29 | $21.03 | $427K | -4.3% | -7.7% | -12.6% |
| KNSA | SELL · 10b5-1 | 2023-12-07 | 2023-12-11 | $17.64 | $983K | +5.9% | +10.3% | +19.6% |
| KNSA | SELL · 10b5-1 | 2023-09-05 | 2023-09-06 | $17.53 | $7K | +0.9% | -4.2% | -0.5% |
| KNSA | SELL | 2023-07-25 | 2023-07-27 | $19.10 | $799K | -4.4% | -7.6% | -18.5% |
| KNSA | SELL | 2022-11-07 | 2022-11-09 | $15.18 | $861K | +5.5% | +3.2% | -6.4% |
| KNSA | SELL | 2020-02-19 | 2020-02-21 | $18.46 | $1.2M | +7.1% | -33.2% | +17.5% |
| KNSA | SELL | 2020-02-13 | 2020-02-18 | $18.29 | $395K | +1.4% | -30.9% | +18.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.